Drug Pipeline

CTX-009 Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
1
Recruiting
1
Phase 3
3
Top Sponsors
2
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-05-15 NCT07392957
Safety and Efficacy of CTX-009 With or Without CTX-471 for Recurrent Glioblastoma		 date change Primary completion pushed: 2029-04-30 -> 2029-05-31
2026-05-15 NCT07392957
Safety and Efficacy of CTX-009 With or Without CTX-471 for Recurrent Glioblastoma		 date change Completion pushed: 2031-04-30 -> 2031-05-31
Active Studies by Phase
Phase 2/3
1
Phase 1/2
2
Active Trials
NCT IDTitleConditionStatus
Phase 2/3
NCT05506943 A Study of CTX-009 in Combination With Paclitaxel in Adult Patients With Unresectable… Biliary Tract Cancer Active, Not Recruiting
Phase 1/2
NCT06548412 CTX-009 With Gemcitabine, Cisplatin, and Durvalumab as First-line Therapy in Patients… Metastatic Biliary Tract Cancer Recruiting
NCT07392957 Safety and Efficacy of CTX-009 With or Without CTX-471 for Recurrent Glioblastoma Glioblastoma Not Yet Recruiting
Sponsors Running CTX-009 Trials
Compass Therapeutics (1) M.D. Anderson Cancer Center (1) Washington University School of Medicine (1)
Disease Areas
Cholangiocarcinoma (2) Bladder Cancer (1) Glioblastoma (1)
Get alerts when CTX-009 trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free